IGF1 and neoplasm: Osteoclast differentiation and activity result in dysregulated bone lysis and release of bone matrix growth factors such as TGFb, insulin-like growth factor 1 (IGF1), fibroblast growth factor (FGF), or bone morphogenetic protein (BMP), which, in turn, can promote tumour cell proliferation and further bone destruction [69,70].